Alimera sciences to present at the 13th annual ld micro main event virtual conference

Atlanta, dec. 08, 2020 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, today announces that ceo rick eiswirth will present a corporate overview at the 13th annual ld micro main event virtual investor conference on monday, december 14 at 8:20 am pst/11:20 am est. the format will be a 10-minute presentation followed by a 10-minute q&a session with a panel of investors and analysts.
ALIM Ratings Summary
ALIM Quant Ranking